Latest ""
Opinion
Innovation as a force muliplier for national security
Bipartisan legislation, like the research and development tax credit which recently passed the House and is headed for the Senate, is essential.
By Andrew Makridis
Paul to oppose small business program Pentagon uses to spur innovation
A key U.S. lawmaker says he will oppose reauthorization of federal small business innovation grants favored by the Pentagon, raising doubts about how Congress will avert their expiration Sept. 30.
Democrats and Republicans agree: government must do more
The Pew Research Center report revealed several benchmarks of public opinion on government efficacy, including the federal response to certain issues and views on politicians. One finding set the tone: “Just 20% say they trust the government in Washington to do the right thing just about always or most of the time.”
New director takes over at Pentagon’s top research office
An experienced veteran of DARPA is taking the helm.
By Andrew Eversden
VA researching prostate cancer drug as potential coronavirus cure
A full trial of the drug degarelix is expected to take at least four months.
Choosing the right commercial tech for government
How can the U.S. government best evaluate commercial tech for the federal market, and avoid reinventing the wheel?
By Meagan Metzger
US says China-backed hackers likely targeting virus researchers
Both the FBI and the U.S. Cybersecurity and Infrastructure Security Agency said that health care and pharmaceutical researchers need to be alert to potential attacks and should take measures to protect their data.
Expert claims reprisal for opposing virus drug Trump touted
Controversy has swirled around the malaria drug hydroxychloroquine since the president started promoting it from the podium in the White House briefing room.
Air Force works to ‘mitigate’ Ligado deal’s impact on GPS
Gen. David Goldfein and other Pentagon officials are "very concerned" after the FCC approved Ligado's L-band request on Monday.
By Aaron Mehta and Valerie Insinna
How past investments positioned DARPA to take on coronavirus
Research investments have accelerated a coronavirus vaccine and, potentially, a new test.
By Andrew Eversden
Pentagon turns to new buying tools 10 times more often
New research by Govini shows that OTA and SBIR contracts account for roughly 10 percent of the Pentagon's spending on research, development, test and evaluation.
By Aaron Mehta